Helle Linnebjerg

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Loop Mediated Isothermal Amplification

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Ronnie Aronson, Torben Biester, Jennifer Leohr, Robyn K Pollom, Helle Linnebjerg, Elizabeth Smith LaBell, Qianyi Zhang, David E Coutant, Thomas Danne
Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents, and adults with type 1 diabetes mellitus. Diabetes, obesity & metabolism (2023)
Tim Heise, Helle Linnebjerg, David Coutant, Elizabeth LaBell, Eric Zijlstra, Christoph Kapitza, Juliana M Bue-Valleskey, Qianyi Zhang, Mary Anne Dellva, Jennifer Leohr
Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study. Diabetes, obesity & metabolism 22 (10) (2020)
Niels K Porksen, Helle Linnebjerg, Eric Chen Quin Lam, Parag Garhyan, Alok Pachori, Richard E Pratley, Steven R Smith
Basal insulin peglispro increases lipid oxidation, metabolic flexibility, thermogenesis and ketone bodies compared to insulin glargine in subjects with type 1 diabetes mellitus. Diabetes, obesity & metabolism 20 (5) (2018)
Rakel F Johansen, Esben Søndergaard, Helle Linnebjerg, Parag Garhyan, Eric C Q Lam, Niels Porksen, Scott J Jacober, Søren Nielsen
Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes. Diabetes, obesity & metabolism 20 (2) (2017)